DE602004030586D1 - Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis - Google Patents
Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitisInfo
- Publication number
- DE602004030586D1 DE602004030586D1 DE602004030586T DE602004030586T DE602004030586D1 DE 602004030586 D1 DE602004030586 D1 DE 602004030586D1 DE 602004030586 T DE602004030586 T DE 602004030586T DE 602004030586 T DE602004030586 T DE 602004030586T DE 602004030586 D1 DE602004030586 D1 DE 602004030586D1
- Authority
- DE
- Germany
- Prior art keywords
- diagnosis
- ankyloider
- cytokin
- spondylitis
- tests
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/104—Lupus erythematosus [SLE]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50313103P | 2003-09-15 | 2003-09-15 | |
PCT/US2004/030059 WO2005029091A2 (en) | 2003-09-15 | 2004-09-15 | Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004030586D1 true DE602004030586D1 (de) | 2011-01-27 |
Family
ID=34375314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004030586T Active DE602004030586D1 (de) | 2003-09-15 | 2004-09-15 | Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis |
Country Status (8)
Country | Link |
---|---|
US (4) | US20060094056A1 (de) |
EP (4) | EP2280286A1 (de) |
JP (1) | JP4711963B2 (de) |
AT (1) | ATE491953T1 (de) |
AU (3) | AU2004274909B8 (de) |
CA (1) | CA2537818A1 (de) |
DE (1) | DE602004030586D1 (de) |
WO (1) | WO2005029091A2 (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7011940B1 (en) * | 1999-04-14 | 2006-03-14 | Medical Discovery Partners Llc | Quality control for cytochemical assays |
DK1882946T3 (da) * | 2003-12-23 | 2010-05-31 | Hoffmann La Roche | Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6 |
FR2875406B1 (fr) * | 2004-09-21 | 2007-01-05 | Danisco | Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal |
US20070141723A1 (en) * | 2005-12-16 | 2007-06-21 | Sompuram Seshi A | Immunohistochemistry staining controls |
US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
US20080015465A1 (en) * | 2006-06-15 | 2008-01-17 | Scuderi Gaetano J | Methods for diagnosing and treating pain in the spinal cord |
JP4734647B2 (ja) * | 2006-08-02 | 2011-07-27 | 国立大学法人金沢大学 | 胸腺腫合併重症筋無力症の診断方法 |
US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
WO2008133641A2 (en) * | 2006-10-11 | 2008-11-06 | Curagen Corporation | Antibodies directed to gpnmb and uses thereof |
ES2386916T3 (es) * | 2006-10-25 | 2012-09-05 | Chu Sainte-Justine | Métodos de diagnosticar osteoartritis |
US20080305512A1 (en) * | 2006-10-26 | 2008-12-11 | Mattingly Phillip G | Assay for cardiac troponin autoantibodies |
MX2009004460A (es) * | 2006-10-26 | 2009-07-09 | Abbott Lab | Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos. |
US7776605B2 (en) * | 2006-10-26 | 2010-08-17 | Abbott Laboratories | Assay for cardiac troponin autoantibodies |
WO2008085963A1 (en) * | 2007-01-05 | 2008-07-17 | University Of Florida Research Foundation, Inc. | Materials and methods for the detection, prevention and treatment of autoimmune disease |
WO2008104608A1 (en) * | 2007-03-01 | 2008-09-04 | Universite Catholique De Louvain | Method for the determination and the classification of rheumatic conditions |
GB0707933D0 (en) * | 2007-04-24 | 2007-05-30 | Apitope Technology Bristol Ltd | Disease markers |
US7709215B2 (en) * | 2007-06-01 | 2010-05-04 | Cytonics Corporation | Method for diagnosing and treating acute joint injury |
WO2008156865A2 (en) * | 2007-06-20 | 2008-12-24 | Schering Corporation | Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease |
US20100261613A1 (en) * | 2007-07-26 | 2010-10-14 | Michael Centola | Methods for inflammatory disease management |
WO2009079773A1 (en) * | 2007-12-21 | 2009-07-02 | Mcmaster University | Method for assessing risk of heart failure |
WO2009107785A1 (ja) | 2008-02-28 | 2009-09-03 | シスメックス株式会社 | Il-17産生ヘルパーt細胞検出用マーカー及びil-17産生ヘルパーt細胞の検出方法 |
US20100255467A1 (en) * | 2008-07-22 | 2010-10-07 | Los Alamos National Security, Llc | Assays for determining exposure to multiwalled carbon nanotubes |
GB2464183A (en) * | 2008-09-19 | 2010-04-14 | Singulex Inc | Sandwich assay |
FI20086145A0 (fi) * | 2008-12-01 | 2008-12-01 | Kansanterveyslaitos | Menetelmä autoimmuunisairauksien osoittamiseksi |
WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
AU2009333489A1 (en) * | 2008-12-30 | 2010-07-08 | Centocor Ortho Biotech Inc. | Serum markers predicting clinical response to anti-TNF antibodies in patients with ankylosing spondylitis |
US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
AU2010213708B2 (en) | 2009-02-11 | 2015-12-10 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
CA2766157A1 (en) * | 2009-06-25 | 2010-12-29 | Hua Gong | Methods for diagnosing irritable bowel syndrome |
KR101486999B1 (ko) * | 2009-07-22 | 2015-01-28 | 씨제이제일제당 주식회사 | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
CN102482667B (zh) | 2009-07-29 | 2014-04-23 | 希森美康株式会社 | 人的产生il-17的辅助性t细胞的检测用标记物及试剂、以及人的产生il-17的辅助性t细胞的检测方法 |
MX353186B (es) * | 2009-09-03 | 2018-01-05 | Genentech Inc | Metodos para el tratamiento, diagnosis y monitoreo de artritis reumatoide. |
EP2488659B1 (de) * | 2009-10-15 | 2019-12-11 | Crescendo Bioscience, Inc. | Biomarker und verfahren zur messung und überwachung der aktivität von entzündungserkrankungen |
WO2011047073A2 (en) * | 2009-10-16 | 2011-04-21 | Mayo Foundation For Medical Education And Research | Assessing rheumatoid arthritis |
KR101178217B1 (ko) * | 2009-10-28 | 2012-09-07 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
JP5275211B2 (ja) * | 2009-12-16 | 2013-08-28 | 猛夫 吉野内 | 間質性肺炎判定マーカーによる判定法 |
EP2336769A1 (de) * | 2009-12-18 | 2011-06-22 | F. Hoffmann-La Roche AG | Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden |
US20130046015A1 (en) | 2010-02-11 | 2013-02-21 | Robert C. Axtell | Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease |
WO2011137306A1 (en) * | 2010-04-30 | 2011-11-03 | University Of Virginia Patent Foundation | System, method and computer program product for the organism-specific diagnosis of septicemia in infants |
EP2566971B1 (de) * | 2010-05-06 | 2019-03-27 | Singulex, Inc. | Verfahren zur diagnose, einstufung und vorhersage des risikos der entwicklung und identifikation von respondern für die behandlung rheumatoider arthritis |
GB201009798D0 (en) * | 2010-06-11 | 2010-07-21 | Immunovia Ab | Method,array and use thereof |
DK3327148T3 (da) * | 2010-06-18 | 2021-04-12 | Myriad Genetics Inc | Fremgangsmåder til forudsigelse af status for brca1- og brca2-gener i en cancercelle |
DK2829881T3 (en) * | 2010-07-14 | 2017-12-04 | Vision Tech Bio Pty Ltd | Colorectal cancer diagnostic |
WO2012021851A2 (en) * | 2010-08-12 | 2012-02-16 | Beth Israel Deaconess Medical Center | Methods and compositions for diagnosing and treating lupus |
US20130303391A1 (en) * | 2010-09-14 | 2013-11-14 | Oklahoma Medical Research Foundation | Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles |
WO2012051317A1 (en) * | 2010-10-12 | 2012-04-19 | Epicgenetics, Llc | Method for diagnosing and treating fibromyalgia |
US20140128276A1 (en) * | 2011-01-13 | 2014-05-08 | Oklahoma Medical Research Foundation | Cytokine profiles as methods for diagnosis and prognosis of irritable bowel syndrome |
JP5946605B2 (ja) | 2011-01-28 | 2016-07-06 | シスメックス株式会社 | ヒトil−17産生ヘルパーt細胞の検出方法 |
US9946836B2 (en) * | 2011-01-31 | 2018-04-17 | Robert Bosch Gmbh | Biomarker monitoring device and method |
AU2012214417A1 (en) * | 2011-02-10 | 2013-09-05 | Genqual Corporation | Methods of prognosing and administering treatment for inflammatory disorders |
WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
WO2013052844A1 (en) | 2011-10-07 | 2013-04-11 | Pulmatrix, Inc. | Methods for treating and diagnosing respiratory tract infections |
US9804156B2 (en) * | 2012-03-06 | 2017-10-31 | Life Technologies Corporation | Biomarkers for systemic lupus erythematosus |
JP2015520383A (ja) * | 2012-06-04 | 2015-07-16 | バイオメット、バイオロジクス、リミテッド、ライアビリティー、カンパニーBiomet Biologics, Llc | 変形性関節症を診断するための方法 |
US20150202286A1 (en) | 2012-07-13 | 2015-07-23 | The Children's Hospital of Philadelphai | Toxicity Management for Anti-Tumor Activity of CARs |
CA2883711A1 (en) | 2012-09-07 | 2014-03-13 | The Governors Of The University Of Alberta | Methods and compositions for diagnosis of inflammatory liver disease |
MX2015003326A (es) | 2012-09-17 | 2015-08-12 | Cedars Sinai Medical Center | Diagnostico y tratamiento de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia. |
WO2014081974A1 (en) * | 2012-11-21 | 2014-05-30 | Massachusetts Institute Of Technology | Biomarkers for dengue fever and use thereof |
GB201223223D0 (en) | 2012-12-21 | 2013-02-06 | Norinnova Technology Transfer As | Inflammatory bowel disease |
US20150005186A1 (en) * | 2013-06-27 | 2015-01-01 | Jing-Feng Huang | Methods and devices for classifying and managing autoimmune and inflammatory conditions |
EP3693738A1 (de) * | 2013-09-20 | 2020-08-12 | Astute Medical, Inc. | Verfahren und zusammensetzungen zur diagnose und prognose von appendizitis und differenzierung von ursachen für bauchschmerzen |
MX2016004283A (es) * | 2013-10-03 | 2016-10-12 | Oklahoma Med Res Found | Biomarcadores para la actividad, e intesidad y arrebato de la enfermedad lupus eritematoso sistemico. |
KR102259588B1 (ko) * | 2013-10-09 | 2021-06-02 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군 및 염증성 장 질환의 진단 및 치료 |
JP6220222B2 (ja) | 2013-10-28 | 2017-10-25 | シスメックス株式会社 | 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品 |
EP3126846A4 (de) | 2014-04-02 | 2017-08-30 | Crescendo Bioscience | Biomarker und verfahren zur messung und überwachung der aktivität von juveniler idiopathischer arthritis |
CA2950771A1 (en) | 2014-06-10 | 2015-12-17 | Crescendo Bioscience | Biomarkers and methods for measuring and monitoring axial spondyloarthritis disease activity |
WO2016014535A1 (en) | 2014-07-21 | 2016-01-28 | Novartis Ag | Treatment of cancer using a cll-1 chimeric antigen receptor |
EP3172237A2 (de) | 2014-07-21 | 2017-05-31 | Novartis AG | Behandlung von krebs mithilfe von humanisiertem chimärem anti-bcma-antigenrezeptor |
CA2962757C (en) * | 2014-09-26 | 2022-03-22 | National University Of Singapore | Methods and compositions for modulating th-gm cell function |
KR102426541B1 (ko) | 2014-10-09 | 2022-07-29 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군을, 염증성 장 질환 및 셀리악 병과 구별하기 위한 방법 및 시스템 |
MX2017004816A (es) * | 2014-10-20 | 2017-08-02 | Nestec Sa | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. |
US10039808B2 (en) * | 2014-10-22 | 2018-08-07 | Michael Chez | Method of treating or improving neurological function in a human subject |
CN104434841B (zh) * | 2014-12-11 | 2017-06-06 | 顺昊细胞生物技术(天津)股份有限公司 | 一种结肠定位复合细胞因子组合物 |
WO2016119044A1 (en) | 2015-01-28 | 2016-08-04 | The Governors Of The University Of Alberta | Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis |
US9925244B1 (en) | 2015-02-17 | 2018-03-27 | Michael Chez | Treatment of warts in non-immunosuppressed patients |
JP6531306B2 (ja) * | 2015-02-20 | 2019-06-19 | 一三 西野 | 炎症性筋疾患鑑別マーカー及びそれを用いた炎症性筋疾患と非炎症性筋疾患の鑑別方法 |
JP6663000B2 (ja) | 2015-05-12 | 2020-03-11 | ザ ジェネラル ホスピタル コーポレーション ドゥーイング ビジネス アズ マサチューセッツ ジェネラル ホスピタル | 関節リウマチの診断のための自己抗原 |
TWI582240B (zh) * | 2015-05-19 | 2017-05-11 | 鄭鴻鈞 | 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置 |
WO2017042381A1 (en) * | 2015-09-11 | 2017-03-16 | Vib Vzw | Means and methods for diagnosing familial mediterranean fever |
JP6565099B2 (ja) * | 2015-09-18 | 2019-08-28 | 国立大学法人 長崎大学 | 家族性地中海熱のバイオマーカー |
WO2017058999A2 (en) | 2015-09-29 | 2017-04-06 | Crescendo Bioscience | Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal |
CA3000192C (en) | 2015-09-29 | 2023-09-26 | Crescendo Bioscience | Biomarkers and methods for assessing psoriatic arthritis disease activity |
EP3463441B1 (de) | 2016-06-07 | 2023-10-25 | The General Hospital Corporation | Identifizierung eines t-zell-epitops von prevotella cori, das t-zell-antworten bei patienten mit rheumatoider arthritis induziert |
US20200080987A1 (en) * | 2016-10-25 | 2020-03-12 | Eccrine Systems, Inc. | Biofluid sensing device cytokine measurement |
US11162943B2 (en) * | 2017-05-31 | 2021-11-02 | Prometheus Biosciences Inc. | Methods for assessing mucosal healing in Crohn's disease patients |
JP7438988B2 (ja) | 2018-06-13 | 2024-02-27 | ノバルティス アーゲー | Bcmaキメラ抗原受容体及びその使用 |
US20210389329A1 (en) * | 2018-10-29 | 2021-12-16 | Thomas Jefferson University | Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders |
US20220276243A1 (en) * | 2019-08-29 | 2022-09-01 | Tohoku University | Inflammatory bowel disease diagnosis method, diagnosis probe and diagnosis kit |
KR102242286B1 (ko) * | 2019-10-02 | 2021-04-20 | 코아스템(주) | 중간엽줄기세포의 신장섬유화 치료효과 예측용 바이오마커 조성물 |
KR102242285B1 (ko) * | 2019-10-02 | 2021-04-20 | 코아스템(주) | 중간엽줄기세포의 전신홍반루푸스 치료효과 예측용 바이오마커 조성물 |
WO2021127008A1 (en) * | 2019-12-16 | 2021-06-24 | The Regents Of The University Of California | Compositions and methods for treating neuromuscular disorders |
RU2743748C1 (ru) * | 2020-06-04 | 2021-02-25 | Светлана Владимировна Панова | Способ ранней диагностики болезни бехтерева в оториноларингологии |
CN113834940A (zh) * | 2021-09-24 | 2021-12-24 | 四川大学华西医院 | 间质性膀胱炎/膀胱疼痛综合征诊断试剂盒 |
EP4361633A1 (de) * | 2022-10-25 | 2024-05-01 | Peptomyc, S.L. | Verfahren zur vorhersage der reaktion auf eine krebsbehandlung |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
WO1990007332A1 (en) | 1986-04-25 | 1990-07-12 | Hitoshi Shichi | Immunosuppressive agent |
US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
US5294698A (en) | 1990-12-06 | 1994-03-15 | Bomalaski John S | Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
WO1993002359A1 (en) | 1991-07-19 | 1993-02-04 | Assay Research, Inc. | Method and kit for measuring endogenous cytokines |
US5965379A (en) * | 1991-07-19 | 1999-10-12 | Cytimmune Sciences Inc. | Method for measuring endogenous cytokines |
AU5542794A (en) * | 1992-10-29 | 1994-05-24 | Miles Inc. | Diagnostic assay for latent matrix metalloproteinase no. 9 |
US5646005A (en) | 1994-04-28 | 1997-07-08 | Kudsk; Kenneth A. | Use of an IL-6 assay for predicting the development of post-trauma complications |
US5658744A (en) | 1994-07-22 | 1997-08-19 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of identifying patients having an altered immune status |
US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
JPH08151373A (ja) * | 1994-09-30 | 1996-06-11 | Kyowa Hakko Kogyo Co Ltd | 生理活性物質ei−1511類およびei−1625−2 |
US6562629B1 (en) * | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US5753442A (en) | 1995-09-01 | 1998-05-19 | Cedars-Sinai Medical Center | Method for determining genetic predisposition for seronegative spondyloarthropathies and products useful therefor |
US6190857B1 (en) * | 1997-03-24 | 2001-02-20 | Urocor, Inc. | Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
US6183951B1 (en) | 1997-04-11 | 2001-02-06 | Prometheus Laboratories, Inc. | Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy |
US6555320B1 (en) | 1998-09-01 | 2003-04-29 | Mayo Foundation For Medical Education And Research | Methods and materials for evaluating rheumatoid arthritis |
US6406884B1 (en) | 1999-06-18 | 2002-06-18 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
US6020165A (en) * | 1998-11-10 | 2000-02-01 | Incyte Pharmaceuticals, Inc. | Cytikine signal regulators |
US6162604A (en) | 1999-04-01 | 2000-12-19 | Jacob; Chaim O. | Methods for determining genetic predisposition to autoimmune diseases by genotyping apoptotic genes |
DE59914482D1 (de) * | 1999-12-16 | 2007-10-11 | Infineon Technologies Ag | Prozessanlage und Prozessverfahren zur Montage von Leadframes |
GB0001448D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
US7912651B2 (en) * | 2000-03-06 | 2011-03-22 | Bioseek Llc | Function homology screening |
US8153121B2 (en) * | 2000-10-06 | 2012-04-10 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
JP2005503533A (ja) | 2001-01-19 | 2005-02-03 | ケンブリッジ サイエンティフィック, インコーポレイテッド | 骨粗鬆症の診断方法および処置方法 |
US6989239B2 (en) | 2001-06-20 | 2006-01-24 | R.E.D. Laboratories, N.V./S.A. | Methods for diagnosis and treatment of chronic immune diseases |
US20030017493A1 (en) | 2001-06-20 | 2003-01-23 | Marc Fremont | Methods for the detection and treatment of chronic immune diseases |
PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
GB0224415D0 (en) * | 2002-10-21 | 2002-11-27 | Medical Res Council | Compositions |
US6919483B2 (en) * | 2003-05-23 | 2005-07-19 | Mediquest Therapeutics, Inc. | Immunomodulation with novel pharmaceutical compositions |
GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
US7928132B2 (en) * | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
-
2004
- 2004-09-15 AU AU2004274909A patent/AU2004274909B8/en not_active Ceased
- 2004-09-15 JP JP2006526977A patent/JP4711963B2/ja not_active Expired - Fee Related
- 2004-09-15 CA CA002537818A patent/CA2537818A1/en not_active Abandoned
- 2004-09-15 EP EP10178582A patent/EP2280286A1/de not_active Withdrawn
- 2004-09-15 AT AT04788750T patent/ATE491953T1/de not_active IP Right Cessation
- 2004-09-15 EP EP10176365A patent/EP2287616A1/de not_active Withdrawn
- 2004-09-15 DE DE602004030586T patent/DE602004030586D1/de active Active
- 2004-09-15 US US10/514,701 patent/US20060094056A1/en not_active Abandoned
- 2004-09-15 WO PCT/US2004/030059 patent/WO2005029091A2/en active Application Filing
- 2004-09-15 EP EP10178562A patent/EP2280285A1/de not_active Withdrawn
- 2004-09-15 EP EP04788750A patent/EP1664796B1/de not_active Not-in-force
-
2009
- 2009-03-24 US US12/410,394 patent/US20090325167A1/en not_active Abandoned
-
2010
- 2010-05-07 AU AU2010201817A patent/AU2010201817B2/en not_active Ceased
- 2010-05-07 AU AU2010201818A patent/AU2010201818A1/en not_active Abandoned
-
2012
- 2012-05-09 US US13/467,680 patent/US20120258883A1/en not_active Abandoned
-
2013
- 2013-09-03 US US14/017,186 patent/US20140005071A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005029091A2 (en) | 2005-03-31 |
AU2010201818A1 (en) | 2010-05-27 |
US20060094056A1 (en) | 2006-05-04 |
AU2004274909A1 (en) | 2005-03-31 |
EP2287616A1 (de) | 2011-02-23 |
AU2010201817B2 (en) | 2012-02-02 |
US20120258883A1 (en) | 2012-10-11 |
US20090325167A1 (en) | 2009-12-31 |
AU2004274909B2 (en) | 2010-02-11 |
WO2005029091A3 (en) | 2005-09-15 |
EP1664796A2 (de) | 2006-06-07 |
EP2280285A1 (de) | 2011-02-02 |
JP2007506100A (ja) | 2007-03-15 |
EP2280286A1 (de) | 2011-02-02 |
US20140005071A1 (en) | 2014-01-02 |
AU2010201817A1 (en) | 2010-05-27 |
AU2004274909B8 (en) | 2010-06-10 |
EP1664796B1 (de) | 2010-12-15 |
CA2537818A1 (en) | 2005-03-31 |
JP4711963B2 (ja) | 2011-06-29 |
ATE491953T1 (de) | 2011-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004030586D1 (de) | Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis | |
ATE510208T1 (de) | Probenanalyseverfahren und probenanalyseeinrichtung | |
DE60303889D1 (de) | Verfahren und System zum Feststellen der Akzeptabilität von Signaldaten, die von einem Prothrombin Zeitteststreifen gesammelt sind | |
WO2004113912A8 (en) | System and method for determining a temperature during analysis of biological fluid | |
ATE361470T1 (de) | Verfahren zur diagnose von immunologischer lebensmittelsensitivität | |
EP3432002A8 (de) | Blutgerinnungsanalysator, blutgerinnungsanalyseverfahren und computerprogramm | |
ATE427067T1 (de) | Verfahren zur detektierung von temperaturanderungen | |
RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
WO2004089187A3 (en) | Caries risk test for predicting and assessing the risk of disease | |
DK1776587T3 (da) | Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf | |
ATE426175T1 (de) | Verfahren zur standardisierung von gerinnungstesten | |
DE602006006855D1 (de) | Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb) | |
ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
JP2011511679A5 (de) | ||
ATE316653T1 (de) | Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe | |
EP1221620A3 (de) | Verfahren zum Ausführen einer Bestimmung der "activated clotting time" mit geringer Empfindlichkeit gegenüber die Anwesenheit des Aprotinins sowie zur Ermittlung der Aprotinin-Empfindlichkeit | |
JP2007248395A5 (de) | ||
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
RU2020127365A (ru) | Способы, применения и комплекты для диагностики пародонтита | |
ITRM20060672A1 (it) | Sistema telematico per l'impiego di strisce diagnostiche reattive e metodo di acquisizione dati di calibratura. | |
ATE302947T1 (de) | Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes | |
DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
DE602004013554D1 (de) | Verbindungen und verfahren zur diagnose von prostatakrebs | |
ATE509270T1 (de) | Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung |